InflammaGen(TM) Therapeutics to Present Case Review of InflammaGen Shok-Pak at ... MarketWatch (press release) InflammaGen Therapeutics is a development-stage, critical care company initially focused on the diagnosis, treatment and prevention of Multiple Organ Failure (MOF), a condition with a high mortality rate and very few therapeutic options. ... |
